Regional brain distribution of metallothionein, zinc and copper in toxic milk mutant and transgenic mice

Toxicology

Volumn 124, Issue 1, 1997, Pages 1-10

  Ono, Shin Ichi ^a   Koropatnick, D James ^b   Cherian, M George ^c  

^a NIHON UNIVERSITY   (Japan)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Metallothionein; MT I; MT I overexpressor transgenic mouse; MT II gene knockout mouse; Toxic milk mutant mouse; Zinc and copper

Indexed keywords

COPPER; METALLOTHIONEIN; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; MALE; MOUSE; MOUSE STRAIN; MUTANT; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BRAIN CHEMISTRY; COPPER; FEMALE; MALE; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; ORGAN SIZE; ZINC;

ANIMALIA; MUS MUSCULUS;

EID: 0030840360     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00133-9     Document Type: Article

References (42)

1. Aschner, M., 1996. The functional significance of brain metallothionein. FAEBS J. 10, 1129-1136.
2. Aschner, M., Cherian, M.G., Klaassen, C.D., Palmiter, R.D., Erickson, J.C., Bush, A.I., 1997. Metallothionein in brain. The role in physiology and pathology. Toxicol. Appl. Pharmacol. 142, 229-242.
3. Biempica, L., Rauch, H., Quintana, N., Sternlieb, I., 1988. Morphologic and chemical studies on a murine mutation (toxic milk mice) resulting in hepatic copper toxicosis. Lab. Invest. 59, 500-508.
4. Blaauwgeers, H.G.T., Sillevis Smitt, P.A.E., de Jong, J.M.B.V., Troost, D., 1993a. Distribution of metallothionein in the human central nervous system. Glia 8, 62-70.
5. Blaauwgeers, H.G.T., Sillevis Smitt, P.A.E., de Jong, J.M.B.V., Troost, D., 1993b. Distribution of metallothionein in the mammalian central nervous system. Biol. Signals 3, 181-187.
6. Bull, P.C., Thomas, G.R., Rommens, J.M., Forbes, J.R., Cox, D.W., 1993. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet. 5, 327-337.
7. Bush, A.I., Pettingell, W.H., Multhaup, G., Paradis, M.D., Vonsattel, J.-P., Gusella, J.F., Beyreuther, K., Masters, C.L., Tanzi, R.E., 1994. Rapid induction of Alzheimer's Aβ amyloid formation by zinc. Science 265, 1464-1467.
8. Cai, L., Koropatnick, J., Cherian, M.G., 1995. Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. Chem.-Biol. Interact. 96, 143-155.
9. Cherian, M.G., Chan, H.M., 1993. Biological functions of metallothionein: A review, in Metallothionein III: Biological roles and medical implications. In: Suzuki, K.T., Kimura, M., Imura, N. (Eds.), Birkhäuser, Boston, pp. 87-109.
10. Choudhuri, S., Kramer, K.K., Berman, N.E., Dalton, T.P., Andrews, G.K., Klaassen, C.D., 1995. Constitutive expression of metallothionein genes in mouse brain. Toxicol. Appl. Pharmacol. 131, 144-154.
11. Connor, J.R., Tucker, P., Johnson, M., Synder, B., 1993. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci. Lett. 159, 80-88.
12. 2+ in rat brain regions. Can. J. Biochem. 51, 87-92.
13. Eaton, D.L., 1985. Effects of various trace metals on the binding of cadmium to rat hepatic Metallothionein determined by the Cd/hemoglobin affinity assay. Toxicol. Appl. Pharmacol. 78, 158-162.
14. Eaton, D.L., Cherian, M.G., 1991. Determination of metallothionein in tissues by cadmium-haemoglobin affinity assay. Methods in enzymology, vol. 205: Metallochemistry, part B, Metallothionein and related molecules. In: Riordan J.F., Vallee B.L. (Eds.), Academic Press, New York, pp. 83-88.
15. Esler, W.P., Stimson, E.R., Jennings, J.M., Ghilardi, J.R., Mantyh, P.W., Maggio, J.E., 1996. Zinc-induced aggregation of human and rat β-amyloid peptides in vitro. J. Neurochem. 66, 723-732.
16. Gasull, T., Giralt, M., Hernandez, J., Martinez, P., Bremner, I., Hidalgo, J., 1994. Regulation of metallothionein concentration in rat brain: Effect of glucocorticoids, zinc, copper, and endotoxin. Am. J. Physiol. 266, E760-E767.
17. Hao, R., Cerutis, D.R., Blaxall, H.S., Rodriguez-Sierra, J.F., Pfeiffer, R.F., Ebadi, M., 1994. Distribution of zinc metallothionein I mRNA in rat brain using in situ hybridization. Neurochem. Res. 19, 761-767.
18. Hidalgo, J., Campmany, L., Marti, O., Armario, A., 1991. Metallothionein-I induction by stress in specific brain areas. Neurochem. Res. 16, 1145-1148.
19. Iszard, M.B., Liu, J., Liu, Y., Dalton, T., Andrews, G.K., Palmiter, R.D., Klaassen, C.D., 1995. Characterization of metallothionein-I-transgenic mice. Toxicol. Appl. Phamacol. 133, 305-312.
20. Kägi, J.H.R., 1993. Evolution, structure and chemical activity of class I metallothioneins: An overview. In Metallothionein III: Biological roles and medical implications. In: Suzuki K.T., Kimura M., Imura, N. (Eds.), Birkhäuser, Boston, pp. 29-55.
21. Kishi, R., Ikeda, T., Miyake, H., Uchino, E., Tsuzuki, T., Inoue, K., 1982. Regional distribution of lead, zinc, iron, and copper in suckling and adult rat brains. Brain Res. 251, 180-182.
22. Koropatnick, D.J., Cherian, M.G., 1993. A mutant mouse (tx) with increased hepatic metallothionein stability and accumulation. Biochem. J. 296, 443-449.
23. Kramer, K.K., Zoelle, J.T., Klaassen, C.D., 1996. Induction of metallothionein mRNA and protein in primary murine neuron cultures. Toxicol. Appl. Pharmacol. 141, 1-7.
24. Lohor, J.B., Browning, J.A., 1995. Free radical involvement in neuropsychiatric illnesses. Review. Psychopharmacol. Bull. 31, 159-165.
25. Masters, B.A., Kelly, E.J., Quaife, C.J., Brinster, R.L., Palmiter, R.D., 1994. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA 91, 584-588.
26. Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C.L., Beyreuther, K., 1996. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271, 1406-1409.
27. Nishimura, N., Nishimura, H., Ghaffar, A., Tohyama, C., 1992. Localization of metallothionein in the brain of rat and mouse. J. Histochem. Cytochem. 40, 309-315.
28. Onosaka, M., Cherian, M.G., 1982. Comparison of metallothionein determination by polarographic and cadmium-saturation assay. Toxicol. Appl. Pharmacol. 63, 270-274.
29. Palmiter, R.D., Sandgren, E.R., Koeller, D.M., Brinster, R.L., 1993. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol. Cell. Biol. 13, 5266-5275.
30. Quaife, C.J., Findley, S.D., Erickson, C.J., Froelick, G.J., Kelly, E.J., Zanbrowicz, B.P., Palmiter, R.D., 1994. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33, 7250-7259.
31. Rauch, H., 1983. Toxic milk, a new mutation affecting copper metabolism in the mouse. J. Hered. 74, 141-144.
32. Santamaria, A., Rios, C., Perez, P., Flores, A., Galvan-Arzate, S., Osario-Rico, L., Solis, F., 1996. Quinolinic acid neurotoxicity. In vivo increased copper and manganese content in rat corpus striatum after quinolinate intrastriatal injection. Toxicol. Lett. 87, 113-119.
33. Schilsky, M.L., Scheinberg, I.H., Sternlieb, I., 1994. Liver transplantation for Wilson's disease. Indications and out-come. Hepatology 19, 583-587.
34. Sillevis Smitt, P.A.E., Mulder, T.P.J., Verspaget, H.W., Blaauwgeers, H.G.T., Troost, D., de Jong, J.M.B.V., 1994. Metallothionein in amyotriphic lateral sclerosis. Biol. Signals 3, 193-197.
35. Stephenson, G.F., Chan, H.M., Cherian, M.G., 1994. Copper-metallothionein from the toxic milk mutant mouse enhances lipid peroxidation initiated by an organic hydroperoxide. Toxicol. Appl. Pharmacol. 125, 90-96.
36. Suzuki, K., Nakajima, K., Otuki, N., Kimura, M., 1994. Metallothionein in developing brain. Biol Signals 3, 188-192.
37. Theophilos, M.B., Cox, D.W., Mercer, J.F., 1996. The toxic milk mouse is a murine model of Wilson disease. Hum. Mol. Genet. 5, 1619-1624.
38. Tully, C.L., Snowdon, D.A., Markesbery, W.R., 1995. Serum zinc, senile plaques, and neurofibrillary tangles. Findings from the NUN study.. Neuroreport 6, 2105-2108.
39. Uchida, Y., Takio, K., Titani, K., Ihara, Y., Tomonaga, Y., 1991. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothioneinlike protein. Neuron 7, 337-347.
40. Winge, D.R., Miklossy, K.-A., 1982. Domain nature of metallothionein. J. Biol. Chem. 7, 3471-3476.
41. Wu, J., Forbes, J.R., Chen, H.S., Cox, D.W., 1994. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat. Genet. 7, 541-545.
42. Zheng, H., Berman, N.E.J., Klaassen, C.D., 1995. Chemical modulation of metallothionein I and III mRNA in mouse brain. Neurochem. Int. 27, 43-58.